LMCG Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Buy
4,287
+46
+1% +$17.1K 0.09% 147
2026
Q1
$1.24M Sell
4,241
-85
-2% -$27.9K 0.07% 147
2025
Q4
$1.52M Sell
4,326
-58
-1% -$19.6K 0.09% 138
2025
Q3
$1.42M Sell
4,384
-531
-11% -$165K 0.08% 142
2025
Q2
$1.91M Sell
4,915
-2,057
-30% -$827K 0.12% 134
2025
Q1
$3.03M Sell
6,972
-12,429
-64% -$4.99M 0.2% 121
2024
Q4
$7.16M Sell
19,401
-597
-3% -$250K 0.44% 78
2024
Q3
$10.4M Sell
19,998
-13
-0.1% -$6.95K 0.63% 59
2024
Q2
$10.8M Sell
20,011
-22
-0.1% -$11.6K 0.63% 57
2024
Q1
$10.4M Sell
20,033
-92
-0.5% -$45.8K 0.61% 62
2023
Q4
$9.49M Sell
20,125
-43
-0.2% -$19.9K 0.59% 61
2023
Q3
$8.78M Sell
20,168
-511
-2% -$232K 0.59% 58
2023
Q2
$9.19M Sell
20,679
-6,140
-23% -$2.83M 0.6% 55
2023
Q1
$12.3M Sell
26,819
-602
-2% -$286K 0.82% 30
2022
Q4
$14.1M Sell
27,421
-1,636
-6% -$831K 0.98% 20
2022
Q3
$13.2M Sell
29,057
-2,262
-7% -$1.08M 0.97% 19
2022
Q2
$15.1M Sell
31,319
-1,492
-5% -$738K 1.04% 19
2022
Q1
$16.1M Buy
+32,811
New +$15M 0.93% 24

Other funds holding ELV

LMCG Investments's ELV Position: Q2 2026 in Review

LMCG Investments increased its Elevance Health (ELV) stake by 1.1% in Q2 2026, buying an estimated $17.1K and bringing the position to 4,287 shares worth $1.66M. The position accounts for 0.09% of the portfolio, ranked #147.

LMCG Investments first reported a position in ELV in Q1 2022 and has held it in 18 quarters since. The position peaked at $16.1M in Q1 2022. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • LMCG Investments held 4,287 shares of Elevance Health worth $1.66M as of Q2 2026.
  • LMCG Investments bought 46 Elevance Health shares in Q2 2026, an estimated $17.1K.
  • Elevance Health made up 0.09% of LMCG Investments's portfolio in Q2 2026, its #147 holding.
  • LMCG Investments first reported a position in Elevance Health in Q1 2022 and has held it in 18 quarters since.
  • LMCG Investments's Elevance Health position peaked at $16.1M in Q1 2022.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on LMCG Investments's 13F filing for Q2 2026, filed 22 Jul 2026.